Table 4.
Estimated rate of BPF decline over 48 weeks (95% CI) |
P‐value | |
---|---|---|
PPMS placebo patients | −0.00254 (−0.00334, −0.00173) | |
SPMS placebo patients | −0.00108 (−0.00195, −0.00022) | |
Difference (PPMS – SPMS) | −0.00146 (−0.00264, −0.00027) | <0.02 |
Estimated rate of BPF decline over 48 weeks (95% CI) |
P‐value | |
---|---|---|
PPMS placebo patients | −0.00254 (−0.00334, −0.00173) | |
SPMS placebo patients | −0.00108 (−0.00195, −0.00022) | |
Difference (PPMS – SPMS) | −0.00146 (−0.00264, −0.00027) | <0.02 |